Back to Search

AMISH PUROHIT, MD

MD

Family Medicine Physician

NPI: 1053413286Individual

Specialties, Licenses & Credentials

Family Medicine PhysicianPrimary

Family Medicine

Code: 207Q00000X

78796(MN)MED-PHYS-139695(MT)18052(ND)17209(NV)17093C(WY)35816(AZ)EMC0001633(MI)42.0017921(VT)U8906(TX)E-15169(AR)CDR.0001523(CO)98592(GA)295426(MA)36163072(IL)

Research & Publications (20)

Development of hormone-dependent prostate cancer models for the evaluation of inhibitors of 17beta-hydroxysteroid dehydrogenase type 3.
PMID 18786604·Mol Cell Endocrinol·2009
7-preclinical
Masitinib, a c-kit/PDGF receptor tyrosine kinase inhibitor, improves disease control in severe corticosteroid-dependent asthmatics.
PMID 19614621·Allergy·2009
3-trial
BCRP expression does not result in resistance to STX140 in vivo, despite the increased expression of BCRP in A2780 cells in vitro after long-term STX140 exposure.
PMID 19156141·Br J Cancer·2009
7-preclinical
Assessment of 18F-labeled mitochondrial complex I inhibitors as PET myocardial perfusion imaging agents in rats, rabbits, and primates.
PMID 18716773·Eur J Nucl Med Mol Imaging·2009
7-preclinical
The development of steroid sulfatase inhibitors for hormone-dependent cancer therapy.
PMID 19250195·Ann N Y Acad Sci·2009
6-review
The design of novel 17beta-hydroxysteroid dehydrogenase type 3 inhibitors.
PMID 18775469·Mol Cell Endocrinol·2009
8-other
Effects of C-17 heterocyclic substituents on the anticancer activity of 2-ethylestra-1,3,5(10)-triene-3-O-sulfamates: synthesis, in vitro evaluation and computational modelling.
PMID 18972041·Org Biomol Chem·2008
8-other
A new therapeutic strategy against hormone-dependent breast cancer: the preclinical development of a dual aromatase and sulfatase inhibitor.
PMID 18927286·Clin Cancer Res·2008
7-preclinical
Synthesis of aromatase inhibitors and dual aromatase steroid sulfatase inhibitors by linking an arylsulfamate motif to 4-(4H-1,2,4-triazol-4-ylamino)benzonitrile: SAR, crystal structures, in vitro and in vivo activities.
PMID 18816537·ChemMedChem·2008
8-other
Clinical effects of immunotherapy with genetically modified recombinant birch pollen Bet v 1 derivatives.
PMID 18564326·Clin Exp Allergy·2008
4-observational

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
161 E RIVULON BLVD STE 210
GILBERT, AZ 85297

Quick Facts

NPI
1053413286
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
14
Locations
1
Publications
20

Are you this provider?

Claim Your Profile